Non-invasive endothelial function assessment in patients with neurofibromatosis type 1: a cross-sectional study

BMC Cardiovascular Disorders

Antonio Luiz P Ribeiro¹  Nilton A Rezende¹  Luisa Lima Castro¹  Luiz Oswaldo C Rodrigues¹  Luiza O Rodrigues¹ 

[1] Department of Internal Medicine, Federal University of Minas Gerais, Av. Prof. Alfredo Balena, 190-246, Belo Horizonte, MG, Cep:30130-100, Brazil

关键词: Reactive hyperemia;    Peripheral arterial tonometry;    Endothelial dysfunction;    Neurofibromatosis type 1;   

Others  :  857808
DOI  :  10.1186/1471-2261-13-18

 received in 2012-07-11, accepted in 2013-02-19,  发布年份 2013

【 摘 要 】

Background

Neurofibromatosis type 1 (NF1) is a multi-systemic disease caused by neurofibromin deficiency. The reduced life expectancy of patients with NF1 has been attributed to NF1-associated malignant neoplasms. However, an analysis of death certificates in the USA suggests that vascular disease could be an important cause of early death among these patients. Endothelial dysfunction (ED) is related to vasculopathy and is an early marker of subclinical atherosclerosis. Since neurofibromin has already been demonstrated to affect endothelial cell function, ED may be associated with NF1. The purpose of this study was to assess endothelial function in patients with NF1 using a non-invasive method.

Methods

NF1 patients and healthy control subjects, aged 18 to 35 years, were included. Subjects were excluded if they had any risk factor for vascular disease or any other condition known to affect endothelial function. Endothelial function was assessed using reactive hyperemia-peripheral arterial tone (RH-PAT) technology. ED was defined as a reactive hyperemia index (RHI) lower than 1.35.

Results

Four of the 29 (13.8%) NF1 patients and 1 of the 30 (3.3%) healthy volunteers had ED (p = 0.153). RHI medians and interquartile intervals were 1.8 (1.58-2.43) for the NF1 group and 2.02 (1.74 – 2.49) for the control group (p = 0.361).

Conclusion

The prevalence of ED was similar in NF1 patients and healthy controls.

【 授权许可】

   
2013 Rodrigues et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C: Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007, 44:81-88. England
• [2]Friedman J, Riccardi V: Clinical and epidemiological features. In Neurofibromatosis: phenotype, natural history, and pathogenesis. 3rd edition. Edited by Friedman J, Gutmann D, Collin M, Riccardi V. Baltimore: The Johns Hopkins University Press; 1999:29-86.
• [3]Rasmussen SA, Yang Q, Friedman JM: Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 2001, 68:1110-1118. United States
• [4]Masocco M, Kodra Y, Vichi M, Conti S, Kanieff M, Pace M, Frova L, Taruscio D: Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995–2006). Orphanet J Rare Dis 2011, 6:11. England BioMed Central Full Text
• [5]Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, McManus B, Korf BR: Cardiovascular disease in neurofibromatosis 1: report of the NF1 cardiovascular task force. Genet Med 2002, 4(3):105-111.
• [6]Gitler AD, Zhu Y, Ismat FA, Lu MM, Yamauchi Y, Parada LF, Epstein JA: Nf1 has an essential role in endothelial cells. Nat Genet 2003, 33:75-79. United States
• [7]Norton KK, Xu J, Gutmann DH: Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. 2nd edition. United States: 1995 Academic Press, Inc; 1995:13-21. [Neurobiol dis]
• [8]Lasater EA, Li F, Bessler WK, Estes ML, Vemula S, Hingtgen CM, Dinauer MC, Kapur R, Conway SJ, Ingram DA Jr: Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans. J Clin Invest 2010, 120(3):859-870.
• [9]Ross R: Atherosclerosis–an inflammatory disease. N Engl J Med 1999, 340(2):115-126.
• [10]De Caterina R, Massaro M, Libby P: Endothelial functions and dysfunctions. In Endothelial dysfunctions in vascular disease. 1st edition. Edited by De Caterina R, Libby P. Malden, MA: Blackwell Futura; 2007:3-25.
• [11]Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Karas RH, Udelson JE: Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003, 146:168-174. United States
• [12]Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A: Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004, 44:2137-2141. United States
• [13]Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP: Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007, 39:1120-1126. United States
• [14]Spurlock G, Bennett E, Chuzhanova N, Thomas N, Jim HP, Side L, Davies S, Haan E, Kerr B, Huson SM: SPRED1 mutations (legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet 2009, 46:431-437. England
• [15]Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, Mitchell GF, Sheffy J, Vita JA, Benjamin EJ: Cross-sectional relations of digital vascular function to cardiovascular risk factors in the framingham heart study. Circulation 2008, 117:2467-2474. United States
• [16]Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, Pumper GM, Lerman LO, Lerman A: Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010, 31:1142-1148. England
• [17]Lekakis J, Abraham P, Balbarini A, Blann A, Boulanger CM, Cockcroft J, Cosentino F, Deanfield J, Gallino A, Ikonomidis I: Methods for evaluating endothelial function: a position statement from the. Eur J Cardiovasc Prev Rehabil 2011, 18(6):775-789.
• [18]Brant LCC, Barreto S, Passos V, Ribeiro ALP: Reprodutibilidade da tonometria arterial periférica para avaliação da função endotelial em adultos brasileiros. vol. 97 edition. Porto Alegre - RS - Brazil: Arquivos Brasileiros de Cardiologia; 2011. [66o Congresso brasileiro de cardiologia]
• [19]Hamburg NM, Palmisano J, Larson MG, Sullivan LM, Lehman BT, Vasan RS, Levy D, Mitchell GF, Vita JA, Benjamin EJ: Relation of brachial and digital measures of vascular function in the community: the framingham heart study. Hypertension 2011, 57:390-396. United States
• [20]Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Luscher TF, Shechter M, Taddei S: The assessment of endothelial function: from research into clinical practice. Circulation 2012, 126:753-767. United States
• [21]Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F, Kurita A: Endothelium-dependent flow-mediated vasodilation in coronary and brachial. Am J Cardiol 1998, 82(12):1535-1539. a1537-1538
• [22]Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM: Predictive value of brachial flow-mediated dilation for incident cardiovascular. Circulation 2009, 120(6):502-509.
• [23]Selamet Tierney ES, Newburger JW, Gauvreau K, Geva J, Coogan E, Colan SD, de Ferranti SD: Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr 2009, 154:901-905. United States
• [24]Haller MJ, Stein J, Shuster J, Theriaque D, Silverstein J, Schatz DA, Earing MG, Lerman A, Mahmud FH: Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Pediatr Diabetes 2007, 8:193-198. Denmark
• [25]Liu J, Wang J, Jin Y, Roethig HJ, Unverdorben M: Variability of peripheral arterial tonometry in the measurement of endothelial function in healthy men. Clin Cardiol 2009, 32(12):700-704.
• [26]Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, Macedo TA, Stanson A: Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg 2007, 46:475-484. United States